BB Lecture 4 ABO

00:00 Introduction 00:15 THE ABO SYSTEM 00:32 IMPORTANCE 00:33 IMPORTANCE 01:16 IMPORTANCE 01:17 IMPORTANCE 03:31 INDICATIONS FOR ABO GROUPING 03:32 INDICATIONS FOR ABO GROUPING 05:58 DISCOVERY OF ABO SYSTEM 05:59 DISCOVERY OF ABO SYSTEM 06:25 1900 Landsteiner’s Experiment 07:28 LANDSTEINER’S RULES 07:29 LANDSTEINER’S RULES 07:54 ABO Groups 11:07 Presentation Paused 11:26 Presentation Resumed 11:28 ABO GROUPS 11:29 ABO GROUPS 11:29 ABO GROUPS 11:29 End of presentation 11:40 ABO Groups 12:21 ABO GROUPS 12:22 ABO GROUPS 13:55 INCIDENCE OF ABO GROUPS - CAUCASIAN POPULATION 13:56 INCIDENCE OF ABO GROUPS - CAUCASIAN POPULATION 14:58 Slide 11 15:43 ABO TYPING REAGENTS - FORWARD GROUPING 15:44 ABO TYPING REAGENTS - FORWARD GROUPING 16:45 Slide 13 17:38 ABO TYPING REAGENTS - REVERSE GROUPING 17:39 ABO TYPING REAGENTS - REVERSE GROUPING 17:39 Slide 0 17:42 Slide 13 18:04 ABO TYPING REAGENTS - REVERSE GROUPING 18:05 ABO TYPING REAGENTS - REVERSE GROUPING 18:57 ABO Typing 21:09 DISCREPANCIES IN TYPING 21:10 DISCREPANCIES IN TYPING 21:37 ABO COMPATIBILITY 21:38 ABO COMPATIBILITY 21:45 ABO COMPATIBILITY 22:17 ABO COMPATIBILITY – PACKED RED CELLS 22:18 ABO COMPATIBILITY – PACKED RED CELLS 22:50 ABO COMPATIBILITY – PACKED RED CELLS 22:51 ABO COMPATIBILITY – PACKED RED CELLS 23:20 ABO COMPATIBILITY – PACKED RED CELLS 23:21 ABO COMPATIBILITY – PACKED RED CELLS 23:51 ABO COMPATIBILITY – PLASMA 23:52 ABO COMPATIBILITY – PLASMA 24:05 ABO COMPATIBILITY – PACKED RED CELLS 24:06 ABO COMPATIBILITY – PACKED RED CELLS 24:06 ABO COMPATIBILITY – PLASMA 24:07 ABO COMPATIBILITY – PLASMA 24:17 ABO COMPATIBILITY - PLASMA 24:18 ABO COMPATIBILITY - PLASMA 24:43 ABO COMPATIBILITY 24:44 ABO COMPATIBILITY 25:23 Slide 0 25:24 Slide 25 25:31 ABO COMPATIBILITY 25:32 ABO COMPATIBILITY 26:18 ABO COMPATIBILITY 26:20 ABO COMPATIBILITY 26:20 ABO COMPATIBILITY 26:21 ABO COMPATIBILITY 26:21 ABO INHERITANCE 26:22 ABO INHERITANCE 26:52 ABO PHENOTYPES 26:53 ABO PHENOTYPES 27:26 Slide 0 27:27 Slide 31 28:06 Slide 32 28:24 CIS-AB PHENOMENON 28:25 CIS-AB PHENOMENON 28:53 CIS-AB PHENOMENON 30:38 CHARACTERISTICS OF ABO ANTIBODIES 30:39 CHARACTERISTICS OF ABO ANTIBODIES 32:21 CHARACTERISTICS OF ABO ANTIGENS 32:22 CHARACTERISTICS OF ABO ANTIGENS 32:51 CHARACTERISTICS OF ABO ANTIGENS 32:52 CHARACTERISTICS OF ABO ANTIGENS 33:53 PRODUCTION OF ABO ANTIGENS 33:54 PRODUCTION OF ABO ANTIGENS 35:12 PRODUCTION OF ABO ANTIGENS 35:13 PRODUCTION OF ABO ANTIGENS 35:20 PRODUCTION OF ABO ANTIGENS 35:21 PRODUCTION OF ABO ANTIGENS 35:24 PRODUCTION OF ABO ANTIGENS 35:25 PRODUCTION OF ABO ANTIGENS 35:34 PRODUCTION OF ABO ANTIGENS 35:35 PRODUCTION OF ABO ANTIGENS 35:55 PRODUCTION OF ABO ANTIGENS 35:56 PRODUCTION OF ABO ANTIGENS 36:08 BOMBAY BLOOD GROUP 36:09 BOMBAY BLOOD GROUP 37:03 BOMBAY BLOOD GROUP 37:04 BOMBAY BLOOD GROUP 37:13 BOMBAY BLOOD GROUP 37:14 BOMBAY BLOOD GROUP 37:14 PRODUCTION OF ABO ANTIGENS 37:14 PRODUCTION OF ABO ANTIGENS 37:14 PRODUCTION OF ABO ANTIGENS 37:15 PRODUCTION OF ABO ANTIGENS 37:27 PRODUCTION OF ABO ANTIGENS 37:28 PRODUCTION OF ABO ANTIGENS 37:28 BOMBAY BLOOD GROUP 37:29 BOMBAY BLOOD GROUP 37:30 BOMBAY BLOOD GROUP 37:31 BOMBAY BLOOD GROUP 38:22 BOMBAY BLOOD GROUP 38:23 BOMBAY BLOOD GROUP 38:38 BOMBAY BLOOD GROUP 38:39 BOMBAY BLOOD GROUP 39:20 LECTINS 39:53 SUBGROUPS 39:54 SUBGROUPS 40:36 SUBGROUPS 40:37 SUBGROUPS 41:23 SUBGROUPS IN TRANSPLANTATION 42:05 SUBGROUP OF A WITH ANTI-A1 42:06 SUBGROUP OF A WITH ANTI-A1 42:39 RESOLVING TYPING PROBLEMS DUE TO SUBGROUPS WITH ANTI-A1 42:54 RESOLVING TYPING PROBLEMS DUE TO SUBGROUPS WITH ANTI-A1 43:24 RESOLVING TYPING PROBLEMS DUE TO SUBGROUPS WITH ANTI-A1 43:25 SUBGROUP OF A WITH ANTI-A1 43:52 RESOLVING TYPING PROBLEMS DUE TO SUBGROUPS WITH ANTI-A1 43:53 RESOLVING TYPING PROBLEMS DUE TO SUBGROUPS WITH ANTI-A1 43:55 RESOLVING TYPING PROBLEMS DUE TO SUBGROUPS WITH ANTI-A1 44:20 OTHER SUBGROUPS 44:21 OTHER SUBGROUPS 45:02 PROBLEMS WITH AX BLOOD TYPE 45:03 PROBLEMS WITH AX BLOOD TYPE 45:22 PROBLEMS WITH AX BLOOD TYPE 45:23 PROBLEMS WITH AX BLOOD TYPE 45:51 PROBLEMS WITH AX BLOOD TYPE 45:52 PROBLEMS WITH AX BLOOD TYPE 46:20 CONCLUSION